[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DE60111228D1 - Heteropolycyclische inhibitoren - Google Patents

Heteropolycyclische inhibitoren

Info

Publication number
DE60111228D1
DE60111228D1 DE60111228T DE60111228T DE60111228D1 DE 60111228 D1 DE60111228 D1 DE 60111228D1 DE 60111228 T DE60111228 T DE 60111228T DE 60111228 T DE60111228 T DE 60111228T DE 60111228 D1 DE60111228 D1 DE 60111228D1
Authority
DE
Germany
Prior art keywords
heteropolycyclic
inhibitors
administering
compound
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60111228T
Other languages
English (en)
Other versions
DE60111228T2 (de
Inventor
Zaihui Zhang
Xinyao Du
Greg Chopiuk
Serguei Sviridov
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novelion Therapeutics Inc
Original Assignee
QLT Inc
Quadra Logic Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by QLT Inc, Quadra Logic Technologies Inc filed Critical QLT Inc
Publication of DE60111228D1 publication Critical patent/DE60111228D1/de
Application granted granted Critical
Publication of DE60111228T2 publication Critical patent/DE60111228T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE60111228T 2000-07-06 2001-07-06 Heteropolycyclische inhibitoren Expired - Fee Related DE60111228T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US61103800A 2000-07-06 2000-07-06
US611038 2000-07-06
PCT/IB2001/001519 WO2002002562A2 (en) 2000-07-06 2001-07-06 Heteropolycyclic inhibitors

Publications (2)

Publication Number Publication Date
DE60111228D1 true DE60111228D1 (de) 2005-07-07
DE60111228T2 DE60111228T2 (de) 2006-03-16

Family

ID=24447360

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60111228T Expired - Fee Related DE60111228T2 (de) 2000-07-06 2001-07-06 Heteropolycyclische inhibitoren

Country Status (8)

Country Link
US (2) US6514972B2 (de)
EP (1) EP1296985B1 (de)
AT (1) ATE296827T1 (de)
AU (1) AU2001277659A1 (de)
CA (1) CA2414885A1 (de)
DE (1) DE60111228T2 (de)
ES (1) ES2243527T3 (de)
WO (1) WO2002002562A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6514972B2 (en) * 2000-07-06 2003-02-04 Kinetek Pharmaceuticals, Inc. Heteropolycyclic inhibitors of protein kinases
US8715708B2 (en) * 2005-08-31 2014-05-06 University Of Maryland Cyclic acetal biomaterials
CA2632635C (en) * 2005-12-08 2014-04-29 Hybrigenics Sa Novel inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications
US7462615B2 (en) * 2005-12-08 2008-12-09 Hybrigenics Sa Inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications
EP1798232A1 (de) * 2005-12-08 2007-06-20 Hybrigenics S.A. Cysteine Proteasehemmer, deren pharmazeutische Zusammensetzungen und therapeutische Anwendungen
MX2009004517A (es) * 2006-10-30 2009-05-13 Hybrigenics Sa Nuevos inhibidores tetraciclicos de las proteasas de cisteina, las composiciones farmaceuticas de las mismas y sus aplicaciones terapeuticas.
US7875613B2 (en) * 2006-10-30 2011-01-25 Hybrigenics Sa Tetracyclic inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications
EP1918292A1 (de) * 2006-10-30 2008-05-07 Hybrigenics S.A. Tetrazyklische Inhibitoren für Cysteinproteasen, pharmazeutische Zubereitungen und therapeutische Anwendungen
WO2012006104A2 (en) * 2010-06-28 2012-01-12 Academia Sinica, Taiwan Compounds and methods for treating tuberculosis infection
CN103520165A (zh) * 2013-10-31 2014-01-22 华东理工大学 茚并三嗪类化合物作为依赖nad(p)h的醌氧化还原酶底物的用途
US10517871B2 (en) 2015-05-15 2019-12-31 Indiana University Research And Technology Corporation Survivin-targeting anti-tumor agents and uses thereof
CN105061360B (zh) * 2015-07-28 2018-06-19 首都师范大学 一种3,4-二氨基-1,2,5-噻二唑的提纯方法
JP2022511371A (ja) 2018-09-28 2022-01-31 アキュセラ インコーポレイテッド Vap-1の阻害剤
CN113368080B (zh) * 2020-02-25 2023-11-17 香港中文大学 稳定的、生物粘附的、扩散限制性团聚体
WO2022103827A1 (en) * 2020-11-10 2022-05-19 New Mexico Tech University Research Park Corporation Kp372-1-induced dna damage as a chemotherapeutic approach to treat cancer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4159375A (en) * 1978-08-24 1979-06-26 American Cyanamid Company 6- AND 7-Aryl-1,2,4-triazolo[4,3-b]-1,2,4-triazines
US4405619A (en) * 1981-09-02 1983-09-20 Diamond Shamrock Corporation Antiinflammatory substituted-1,2,4-triazolo[4,3-b]-1,2,4-triazines
GB8826237D0 (en) 1988-11-09 1988-12-14 Univ Belfast Fingerprint reagent
WO1995024190A2 (en) 1994-03-07 1995-09-14 Sugen, Inc. Receptor tyrosine kinase inhibitors for inhibiting cell proliferative disorders and compositions thereof
AU2001240021A1 (en) * 2000-04-13 2001-10-30 Millennium Pharmaceuticals, Inc. Diazafluorenone il-8 receptor antagonists
US6514972B2 (en) * 2000-07-06 2003-02-04 Kinetek Pharmaceuticals, Inc. Heteropolycyclic inhibitors of protein kinases

Also Published As

Publication number Publication date
US20020035251A1 (en) 2002-03-21
CA2414885A1 (en) 2002-01-10
US20030144294A1 (en) 2003-07-31
WO2002002562A3 (en) 2002-05-02
EP1296985A2 (de) 2003-04-02
AU2001277659A1 (en) 2002-01-14
ATE296827T1 (de) 2005-06-15
WO2002002562A2 (en) 2002-01-10
DE60111228T2 (de) 2006-03-16
US7196083B2 (en) 2007-03-27
US6514972B2 (en) 2003-02-04
EP1296985B1 (de) 2005-06-01
ES2243527T3 (es) 2005-12-01

Similar Documents

Publication Publication Date Title
ATE296827T1 (de) Heteropolycyclische inhibitoren
DK1223980T3 (da) Anvendelse af CSF-1-inhibitorer
CY1108738T1 (el) Θεραπευτικοι παραγοντες χρησιμοι για την αγωγη του πονου
ATE377004T1 (de) Proteinkinaseinhibitoren
DE60331187D1 (de) Kinaseinhibitoren
DOP2001000151A (es) Derivados de imidazopirimidina y derivados de triazolopimidina.
DE60335359D1 (de) Phthalazinonderivate
EA200300906A1 (ru) Новые спиротрициклические производные и их применение в качестве ингибиторов фосфодиэстеразы-7
BG106585A (en) Kinase inhibitors as therapeutic agents
CY1107634T1 (el) Φαρμακευτικη συνθεση
EA200200769A1 (ru) Ингибиторы гиразы и их применение
HRP20090159T1 (en) Use of glucosidase inhibitors for therapy of mucovisidosis
CY1111396T1 (el) Ρινικη χορηγηση μετοκλοπραμιδης για την αγωγη της γαστροπαρεσης
SE0104248D0 (sv) Method of treatment
EA200101077A1 (ru) Композиция для профилактики или лечения слабоумия, включающая производное гидроксикоричной кислоты или экстракт растения рода angelicae, содержащий его
SE0301232D0 (sv) Novel use
DK1458393T3 (da) Substituerede diketopiperaziner som oxytocinantagonister
GB9903403D0 (en) Substituted stilbene compounds with vascular damaging activity
MY143245A (en) 4- 2-(cycloalkylamino)pyrimidin-4-yl-(phenyl)-imidazolin-2-one derivatives as p38 map-kinase inhibitors for the treatment of inflammatory diseases
MY139228A (en) Imidazolinylmethyl aralkylsulfonamides
SE0004827D0 (sv) Therapeutic compounds
MXPA03000337A (es) Inhibidores de trombina que comprenden un grupo aminoisoquinolina.
MXPA05003909A (es) Compuestos de benzopiranona, composiciones de los mismos, y metodos para el tratamiento o prevencion del cancer.
RS50449B (sr) Supstituisani bisindolilmaleimidi za inhibiciju proliferacije ćelija
DE60108873D1 (de) Nicht-antibakterielle tetrazykline als anti-pilz medikamente

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee